Leaflet MEGACE 160 160mg tablets

Indicated for: cachexia; breast or endometrial cancer

Route of administration: oral

Substance: megestrol (antineoplastic agent)

ATC: L02AB01 (Antineoplastic and immunomodulating agents | Hormones and related agents | Progestogens)

Precautions:
Fertility warning
Fertility warning

This medicine may affect fertility.

Dose adjustment in hepatic impairment
Dose adjustment in hepatic impairment

Dose adjustment may be needed in liver disease.

Cytotoxic / special handling
Cytotoxic / special handling

Handle with special care.

Contraception required
Contraception required

Effective contraception is required during treatment.

Contraindicated during breastfeeding
Contraindicated during breastfeeding

Do not use this medicine while breastfeeding.

Contraindicated during pregnancy
Contraindicated during pregnancy

Do not use this medicine during pregnancy.

Hepatotoxicity
Hepatotoxicity

This medicine may affect the liver.

Major drug interactions
Major drug interactions

This medicine may have important interactions with other medicines.

Myelosuppression / agranulocytosis
Myelosuppression / agranulocytosis

This medicine may lower blood cell counts.

Additional monitoring
Additional monitoring

This medicine is subject to additional monitoring.

Requires periodic laboratory tests
Requires periodic laboratory tests

Periodic laboratory tests may be required during treatment.

Severe skin reactions
Severe skin reactions

Stop taking the medicine and seek urgent medical help if a severe rash occurs.

Megestrol is a medication primarily used to treat breast cancer and endometrial cancer. It is also used to stimulate appetite and prevent weight loss in patients with chronic illnesses such as AIDS or advanced cancer.

This drug belongs to the class of progestins and works by altering hormonal balance, inhibiting the growth of hormone-sensitive cancer cells. Additionally, megestrol can help increase body mass by stimulating appetite.

Megestrol is available in tablet or oral suspension form, and the dosage is adjusted based on the condition being treated and the patient's response. Treatment may have side effects such as weight gain, fluid retention, mood changes, or gastrointestinal disturbances.

Patients taking megestrol should be regularly monitored by their doctor, especially if they have a history of thrombosis or other cardiovascular conditions. Pregnant or breastfeeding women should not use this medication.

General data about MEGACE 160 160mg

  • Substance: megestrol
  • Date of latest medicines list: 01-07-2013
  • Product code: W04101002
  • Concentration: 160mg
  • Pharmaceutical form: tablets
  • Quantity: 30
  • Product type: Original
  • Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Pharmaceutical forms available for megestrol

Concentrations available for megestrol

  • 160mg
  • 40mg
  • 40mg/ml